Zacks Investment Research The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Aligos Therapeutics, Inc. (ALGS) one of those stocks right...\n more…
Benzinga Clover Health Investments's CLOV short percent of float has fallen 9.75% since its last report. The company recently reported that it has 29.36 million shares sold short, which is 7.31% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.34 days to cover their short positions on average.\n more…
BizJournals.com - Nat'l Business News Clover Health Investments Corp.'s AI company Counterpart Health has partnered with a Midwest company to expand its presence. Here's who it partnered with, what that partnership entails and how Counterpart Health came to be.\n more…
Globe Newswire FRANKLIN, Tenn., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Today, Counterpart Health, Inc. ( Counterpart ), a leading AI-powered physician enablement platform, announced a multi-year agreement with The...\n more…
Ticker Report Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) was the recipient of some unusual options trading on Thursday. Investors acquired 28,694 call options on the stock. This represents an...\n more…